| mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.00064 |
1 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.00046 |
1 |
| mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.00043 |
1 |
| mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
-0.00038 |
1 |
| mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.00034 |
1 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00022 |
1 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00019 |
1 |
| mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.00013 |
1 |
| mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
5e-05 |
1 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
1.2e-05 |
1 |